News

Pill penalty disincentivizes R&D At a superficial level this results in somewhat lower drug prices, but it disincentivizes ...
While state court challenges have stalled out, a new federal suit tries to advance the battle between Texas’ abortion laws ...
A new home-based brain stimulation system uses AI to personalize low-level electrical stimulation and boost attention. In a ...
The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.
In a significant victory for pharmaceutical competition and access to generic drugs, Jenner & Block secured a key litigation win on behalf of ...
If you need to clean your toilet but you are out of cleaner, check out your medicine cabinet. This simple hack can clean your ...
Promising review: "I am a flight attendant, and I LOVE this organizer! I keep my iPad, passport, cords, paperwork, and hand ...
Brut India on MSN5d
Woman’s story
Marriage Is Dying in India, And Women Are Glad It Is China's First 4th-Gen Green Homes – Vertical Forest Apartments with Giant Balconies and Futuristic Design India vs England 4th Test: Massive blow ...
Inspired by a hitchhiking fish that uses a specialized suction organ to latch onto sharks and other marine animals, ...
BioMarin Pharmaceuticals is one of many biotech companies that’s laid off workers over the past two years. Its office in ...
As Cipla turns 90, the pharmaceutical giant is reimagining itself as a brand fit for a wellness-driven, digital-first India.
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.